Prostate Cancer - Results from #2180

Opposing Roles of SPOP Mutations in Human Prostate and Endometrial Cancers. September 14, 2023

Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer. September 14, 2023

Racial differences in serum chemokines in prostate cancer patients. September 14, 2023

Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. September 14, 2023

Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance. September 14, 2023

Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary Proteomes. September 14, 2023

Discovery of BWA-522, a First-in-Class and Orally Bioavailable PROTAC Degrader of the Androgen Receptor Targeting N-Terminal Domain for the Treatment of Prostate Cancer. September 14, 2023

Transcriptomic Signatures Associated With Outcomes in Recurrent Prostate Cancer Treated With Salvage Radiation, Androgen-Deprivation Therapy, and Enzalutamide: Correlative Analysis of the STREAM Trial. September 14, 2023

Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis. September 14, 2023

Evolution of structural rearrangements in prostate cancer intracranial metastases. September 14, 2023

BOP Preliminary Trial Results Presented at EANM 2023 Conference September 13, 2023

Evaluation of Industry Payments to US Advanced Practice Clinicians in 2021 September 13, 2023

Racial and ethnic differences in perceptions of germline or somatic DNA sequencing among patients with advanced prostate, urothelial, or kidney cancer. September 13, 2023

Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer. September 13, 2023

Barriers and enablers of active surveillance for prostate cancer - a qualitive study of clinicians. September 13, 2023

Association between common urologic medications and onset of Alzheimer's disease and related dementias in men with prostate cancer managed by different primary treatment modalities. September 13, 2023

Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort. September 13, 2023

Mount Sinai Awarded $3.4 Million to Study Prostate Cancer in People With HIV September 12, 2023

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines. September 12, 2023

Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion. September 12, 2023

Page 110 of 1439